The keynote presentation will be delivered by the firm’s CEO and VP of Research & Development Dr Gregory Lambert, who said: “The challenges of overweight, obesity and their associated conditions are an increasing public concern in the Asia Pacific region. The rise in the prevalence of overweight and obesity is, in part, a negative consequence of the increasing economic developments of many lower- and middle-income countries in this region.
TargEDys, a French clinical stage biotech company, has identified a new mechanism of appetite regulation via the microbiome that could be the solution to this problem.
“TargEDys’ innovative, satiety inducing technology (ProbioSatys®) is based on a commensal, enterobacteria probiotic strain, Hafnia alvei, that produces the ClpB protein, a mimetic of the satiety hormone α-MSH. The mechanism of Hafnia has been proven in vitro and in vivo and tested in humans,” added Dr Lambert.
He will present the first ‘real life’ efficacy results at the summit, which takes place from October 22-24 at the Hilton on Orchard Road.
Key takeaways will include
• The challenges of overweight populations – Global and APAC Regions.
• Details of the new microbiome led, molecular mechanism of appetite regulation - ProbioSatys and the strain Hafnia alvei 4597
• The mechanism of Hafnia and clinical study findings
A pharmacist, with a PhD in pharmaceutical technology, Gregory’s career has been split between Biotech and Pharma as Chief Scientific Officer and Chief Executive Officer in companies such as Novagali Pharma, Septodont and currently TargEDys.
He joins fellow confirmed speakers:
- Dr Sam Costello, Consultant Gastroenterologist and Head of IBD Research at The Queen Elizabeth Hospital in Adelaide
- Dr Natarajan Ranganathan, Founder and Managing Director of Kibow Biotech Inc
- Thomas Hayes, Analyst, Emerging Ecosystems in Agrifood & Health, Lux Research
- Dr Vineet Sharma, Associate Professor, Metagenomics and Systems Biology Laboratory, Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, India
- Lillian Fan, Antion (Beijing) Information Consulting Co., Ltd
- Dr Bejit Ideas, Laboratory Director, Japanese Society of Anti-Aging Nutrition
- Rieko Shofu, Founder, Sensing Asia
- Ewa Hudson, Director of Insights, Lumina Intelligence, William Reed Business Media
- Dr Anders Henriksson, Research Fellow, Food Science and Technology
- Programme, Department of Chemistry, National University of Singapore
- Dr Shanthi Parkar, Science Team Leader, Microbiome & Metabolism, New Zealand of Plant & Food Research
This is the third year the event, organised by NutraIngredients-Asia, part of William Reed, has been held in Asia.
Regional Head of APAC at William Reed, and NutraIngredients-Asia Editor-in-Chief Gary Scattergood said: “After two hugely successful years, we are delighted to bring Probiota Asia back to Singapore for year three.
“In a short space of time, the event has become the region’s leading summit for industry and academia interested in the areas of probiotics, prebiotics and the microbiome, and we look forward to welcoming a stellar line-up of speakers.”
A significant part of the summit will look at the link between the microbiome, nutrition, and a raft of health conditions, alongside major market insights, regulatory developments and consumer trends.
The 2019 event has already received sponsorship backing from valued partners DuPont, AB-Biotics, Morinaga, UASLabs, and Nutrasource.
To register, visit: https://www.probiotaasia.com/register/
For sponsorship and commercial partnership queries, please contact Sue Ann Peh or Tim Evans.
